Not Yet RecruitingPhase 4ACTRN12605000745640
Does metoclopramide improve quality of endoscopy in acute upper gastrointestinal bleeding?.
Sponsor
Pharmacy department , Southerm Health.
Enrollment
70 participants
Start Date
May 15, 2006
Study Type
Interventional
Conditions
Eligibility
Sex: Both males and femalesMin Age: 18 Yearss
Inclusion Criteria1
- Upper GI bleeding defined as either fresh and bright red or coffee ground haematemesis, Admission within 12 hours of initial clinical signs of bleeding and Written informed consent from patient.
Exclusion Criteria1
- Previous allergy to metoclopramide, use of Nasogastric tube or gastric lavage, Prior gastrectomy, Pregnancy or lactation, Unable to give informed consent for any reason, Parkinsons disease and other contraindication to use of metoclopramide, Severe renal impairment and Advanced liver disease .
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
This study aims to investigate whether the administration of intravenous 10mg metoclopramide, 30-60minutes prior to endoscopy will improve the quality of endoscopic examination, will reduce the durati
This study aims to investigate whether the administration of intravenous 10mg metoclopramide, 30-60minutes prior to endoscopy will improve the quality of endoscopic examination, will reduce the duration of endoscopic procedure and will decrease the need for repeat endoscopy
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12605000745640
Related Trials
OTSC vs. Angiographic Embolization in Patients With Refractory Non-variceal Upper Gastrointestinal Bleeding
NCT049022485 locations
PuraStat® Combined With Adrenaline Versus Standard of Care in Upper Gastrointestinal Bleeding
NCT068964091 location
A prospective validation study of the Glasgow-Blatchford score
ACTRN126170006543581 location